Sebetralstat

CAS No.	1933514-13-6
MDL No.	N/A
MF	C₂₆H₂₆FN₅O₄
MW	491.50
InChI Key	KGMPDQIYDKKXRD-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1933514-13-6
Product Name	Sebetralstat

Associated Conditions

hereditary angioedema·angioedema

* The information provided here is compiled from public sources and is for reference only.

Sebetralstat

CAS No.	1933514-13-6
MDL No.	N/A
MF	C₂₆H₂₆FN₅O₄
MW	491.50
InChI Key	KGMPDQIYDKKXRD-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1933514-13-6
Product Name	Sebetralstat

Associated Conditions

hereditary angioedema·angioedema

* The information provided here is compiled from public sources and is for reference only.

Sebetralstat

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Sebetralstat

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Documentation

Sebetralstat

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Related Articles

Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.

Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema.

Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.

KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results.

Sebetralstat

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Related Articles

Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.

Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema.

Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.

KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results.

Documentation